Merck & Co Inc at Morgan Stanley Global Healthcare Conference (Virtual) Transcript
Pleasure to introduce the session with Merck. I need to refer you to disclaimers at www.morganstanley.com/researchdisclosures. And it's very much my pleasure to welcome the Chairman and CEO, Ken Frazier; and also the Head of R&D, Dr. Roger Perlmutter with us. As you know, these 2 individuals are leading the company's mission and vision to lead Merck to continue to be the premier biopharmaceutical research company in the world. Congratulations on your recent progress and momentum. Ken, let me turn it over to you for prepared remarks, and then we'll go from there.
Thanks, David. Thanks for having us today. I would just start by saying -- start where you just left off, which is at Merck, we will consistently focus on science as core to our strategy. Our view is that we should
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
